ESR1 and breast carcinoma: The first miRNA study in breast cancer indicated differential expression of miRNAs in concordance with other well-established markers of breast cancer stage and patient prognosis including ERα and PR expression, tumor stage, number of positive lymph nodes, and vascular invasion [20].